BackgroundPrimary Sclerosing Cholangitis (PSC) is a chronic heterogenous cholangiopathy with unknown etiology where chronic inflammation of the bile ducts leads to multifocal biliary strictures and biliary fibrosis with consecutive cirrhosis development. We here aimed to identify a PSC-specific gene signature associated with biliary fibrosis development. MethodsWe performed RNA-sequencing of 47 liver biopsies from people with PSC (n = 16), primary biliary cholangitis (PBC, n = 15), and metabolic dysfunction-associated steatotic liver disease (MASLD, n = 16) with different fibrosis stages to identify a PSC-specific gene signature associated with biliary fibrosis progression. For validation, we compared an external transcriptome data set of liver biopsies from people with PSC (n = 73) with different fibrosis stages (DOI: 10.1002/hep.31488; baseline samples from NCT01672853). ResultsDifferential gene expression analysis of the liver transcriptome from PSC patients with advanced versus early fibrosis revealed 431 genes associated with fibrosis development. Of those, 367 were identified as PSC-associated when compared to PBC or MASLD. Validation against an external data set of 73 liver biopsies from PSC patients with different fibrosis stages led to a condensed set of 150 (out of 367) DEGs. Cell type specificity assignment of those genes by using published single cell RNA-seq data revealed genetic disease drivers expressed by cholangiocytes (e.g. CXCL1, SPP1), fibroblasts, innate and adaptive immune cells while deconvolution along fibrosis progression of the PSC, PBC, MASLD samples highlighted an early involvement of macrophage- and neutrophil-associated genes in PSC fibrosis. ConclusionWe reveal a PSC-attributed gene signature associated with biliary fibrosis development that may enable the identification of potential new biomarkers and therapeutic targets in PSC-related fibrogenesis. IMPACT AND IMPLICATIONSPrimary sclerosing cholangitis (PSC) is an inflammatory liver disease that is characterized by multifocal inflammation of bile ducts and subsequent biliary fibrosis. Herein, we identify a PSC-specific gene set of biliary fibrosis progression attributing to a uniquely complex milieu of different cell types, including innate and adaptive immune cells while neutrophils and macrophages showed an earlier involvement in fibrosis initiation in PSC in contrast to PBC and MASLD. Thus, our unbiased approach lays an important groundwork for further mechanistic studies for research into PSC-specific fibrosis.
Read full abstract